Myricetin 3-methyl-3-O-rutinoside
CAS No. 55481-90-8
Myricetin 3-methyl-3-O-rutinoside( ——— )
Catalog No. M38978 CAS No. 55481-90-8
Myricetin 3'-methyl-3-O-rutinoside
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMyricetin 3-methyl-3-O-rutinoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionMyricetin 3'-methyl-3-O-rutinoside
-
DescriptionMyricetin 3'-methyl-3-O-rutinoside
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number55481-90-8
-
Formula Weight640.543
-
Molecular FormulaC28H32O17
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
4',?7-?Di-?O-?methyl...
4',?7-?Di-?O-?methylnaringenin is a natural product.
-
Licarin A b
Licarin A ((+)-Licarin A), a neolignan, significantly and dose-dependently reduces TNF-α production (IC50=12.6 μM) in dinitrophenyl-human serum albumin (DNP-HSA)-stimulated RBL-2H3 cells. Anti-allergic effects. Licarin A reduces TNF-α and PGD2 production, and COX-2 expression.
-
Salcaprozate sodium
Salcaprozate sodium is an oral absorption promoter, and has the potential as a delivery agent for oral forms of heparin and insulin.
Cart
sales@molnova.com